CuraScientific Corp
CSTF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -60.1% | 43.4% | -26.1% | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | -$1 | $0 | $0 | $0 |
| % Margin | -3,298.1% | 64.1% | 69.3% | 67.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $4 | $2 | $0 |
| SG&A Expenses | $2 | $4 | $2 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$0 |
| Other Operating Expenses | -$1 | $1 | $0 | $0 |
| Operating Expenses | $1 | $5 | $3 | $0 |
| Operating Income | -$2 | -$5 | -$3 | $0 |
| % Margin | -6,910.9% | -5,537.1% | -4,210.4% | 3.6% |
| Other Income/Exp. Net | -$3 | -$1 | -$2 | -$0 |
| Pre-Tax Income | -$5 | -$6 | -$5 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$6 | -$5 | -$0 |
| % Margin | -15,299.2% | -6,805.1% | -8,085.5% | -13.1% |
| EPS | -1.11 | -19.32 | -82.4 | -17.39 |
| % Growth | 94.3% | 76.6% | -373.8% | – |
| EPS Diluted | -1.11 | -19.32 | -82.4 | -17.39 |
| Weighted Avg Shares Out | 5 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 5 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$3 | -$4 | -$4 | $0 |
| % Margin | -9,969.6% | -4,754.9% | -6,831.3% | 17.1% |